Immunosenescence and macrophage functional plasticity: Dysregulation of macrophage function by age-associated microenvironmental changes

Immunological Reviews

Volumn 205, Issue , 2005, Pages 60-71

  Stout, Robert D ^a   Suttles, Jill ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CATECHOLAMINE; CELL SURFACE RECEPTOR; COMPLEMENT; CYTOKINE; FATTY ACID BINDING PROTEIN; FC RECEPTOR; GAMMA INTERFERON; GLUCOCORTICOID; HISTAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTEGRIN; INTERLEUKIN RECEPTOR; LEUKOTRIENE C4; LIGAND; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NUCLEOTIDE BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROSTAGLANDIN E2; SOMATOMEDIN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADAPTATION; AGING; ANIMAL CELL; ANTIGEN PRESENTATION; ENVIRONMENTAL CHANGE; IMMUNE RESPONSE; IMMUNOGENICITY; MACROPHAGE ACTIVATION; MICROENVIRONMENT; NERVE CELL PLASTICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; STROMA CELL; TISSUE INJURY;

AGING; ANIMALS; CELL LINEAGE; HUMANS; IMMUNE SYSTEM; MACROPHAGES; SIGNAL TRANSDUCTION;

EID: 20344384993     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2005.00260.x     Document Type: Review

References (192)

1. Linton PJ, Haynes L, Tsui L, Zhang X, Swain S. From naive to effector - alterations with aging. Immunol Rev 1997;160:9-18.
2. Linton PJ, Haynes L, Klinman NR, Swain SL. Antigen-independent changes in naive CD4 T cells with aging. J Exp Med 1996;184: 1891-1900.
3. Hu A, et al. Effect of age on the expressed B cell repertoire: role of B cell subsets. Int Immunol 1993;5:1035-1039.
4. Johnson SA, Cambier JC. Ageing, autoimmunity and arthritis: senescence of the B cell compartment - implications for humoral immunity. Arthritis Res Ther 2004;6:131-139.
5. Beverley PC, Grubeck-Loebenstein B. Is immune senescence reversible? Vaccine 2000;18:1721-1724.
6. Franceschi C, Bonafe M, Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 2000;18:1717-1720.
7. Haynes L, Eaton SM, Burns EM, Rincon M, Swain SL. Inflammatory cytokines overcome age-related defects in CD4 T cell responses in vivo. J Immunol 2004;172:5194-5199.
8. Uyemura K, Castle SC, Makinodan T. The frail elderly: role of dendritic cells in the susceptibility of infection. Mech Ageing Dev 2002;123:955-962.
9. Garcia GG, Miller RA. Age-related defects in CD4+ T cell activation reversed by glycoprotein endopeptidase. Eur J Immunol 2003;33:3464-3472.
10. Plackett TP, Boehmer ED, Faunce DE, Kovacs EJ. Aging and innate immune cells. J Leukoc Biol 2004;76:291-299.
11. Unanue ER. Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response. Immunol Rev 1997;158:11-25.
12. Williams K, Dooley N, Ulvestad E, Becher B, Antel JP. IL-10 production by adult human derived microglial cells. Neurochem Int 1996;29:55-64.
13. Hausser G, Ludewig B, Gelderblom HR, Tsunetsugu-Yokota Y, Akagawa K, Meyerhans A. Monocyte-derived dendritic cells represent a transient stage of differentiation in the myeloid lineage. Immunobiology 1997;197:534-542.
14. Anderson CF, Mosser DM. A novel phenotype for an activated macrophage: the type 2 activated macrophage. J Leukoc Biol 2002;72:101-106.
15. Anderson CF, Mosser DM. Cutting edge: biasing immune responses by directing antigen to macrophage Fc gamma receptors. J Immunol 2002;168:3697-3701.
16. Shortman K, Wu L. Are dendritic cells end cells? Nat Immunol 2004;5:1105-1106.
17. Zhang M, et al. Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells. Nat Immunol 2004;5:1124-1133.
18. Wu D, Meydani SN. Mechanism of age-associated up-regulation in macrophage PGE2 synthesis. Brain Behav Immun 2004;18:487-494.
19. Apolloni E, et al. Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes. J Immunol 2000;165:6723-6730.
20. Koblish HK, Hunter CA, Wysocka M, Trinchieri G, Lee WM. Immune suppression by recombinant interleukin (rIL)-12 involves interferon gamma induction of nitric oxide synthase 2 (iNOS) activity: inhibitors of NO generation reveal the extent of rIL-12 vaccine adjuvant effect. J Exp Med 1998;188:1603-1610.
21. Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002;196:254-265.
22. Mosser DM. The many faces of macrophage activation. J Leukoc Biol 2003;73:209-212.
23. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3:23-35.
24. Stout RD, Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 2004;76:509-513.
25. Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, Dayer JM. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 1995;96:2304-2310.
26. Lacraz S, Nicod L, Galve-de Rochemonteix B, Baumberger C, Dayer JM, Welgus HG. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J Clin Invest 1992;90:382-388.
27. Mostafa ME, et al. Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion. Cardiovasc Res 2001;49:882-890.
28. Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 2004;9:283-289.
29. Lucas M, Stuart LM, Savill J, Lacy-Hulbert A. Apoptotic cells and innate immune stimuli combine to regulate macrophage cytokine secretion. J Immunol 2003;171:2610-2615.
30. Gratchev A, Schledzewski K, Guillot P, Goerdt S. Alternatively activated antigen-presenting cells: molecular repertoire, immune regulation, and healing. Skin Pharmacol Appl Skin Physiol 2001;14:272-279.
31. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000;164:6166-6173.
32. Stout RD, Suttles J. T cell signaling of macrophage activation. Cell contact-dependent and cytokine signals. Austin: R. G. Landes Company, Springer-Verlag, 1995.
33. Golpon HA, et al. Life after corpse engulfment: phagocytosis of apoptotic cells leads to VEGF secretion and cell growth. FASEB J 2004;18:1716-1718.
34. Cvetanovic M, Ucker DS. Innate immune discrimination of apoptotic cells: repression of proinflammatory macrophage transcription is coupled directly to specific recognition. J Immunol 2004;172:880-889.
35. McGrath MS, Kodelja V. Balanced macrophage activation hypothesis: a biological model for development of drugs targeted at macrophage functional states. Pathobiology 1999;67:277-281.
36. Allavena P, et al. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur J Immunol 1998;28:359-369.
37. Munder M, Eichmann K, Modolell M. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J Immunol 1998;160:5347-5354.
38. Munder M, Eichmann K, Moran JM, Centeno F, Soler G, Modolell M. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J Immunol 1999;163:3771-3777.
39. Stout RD, Suttles J. The many roles of CD40 in cell-mediated inflammatory responses. Immunol Today 1996;17:487-492.
40. Wagner DH, Stout RD, Suttles J. Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte IL-1 synthesis. Eur J Immunol 1994;24:3148-3154.
41. Suttles J, Evans M, Miller RW, Poe JC, Stout RD, Wahl LM. T cell rescue of monocytes from apoptosis: role of the CD40-CD40L interaction and requirement for CD40-mediated induction of protein tyrosine kinase activity. J Leukoc Biol 1996;60:651-657.
42. Stout RD, Suttles J, Xu J, Grewal IS, Flavell RA. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J Immunol 1996;156:8-12.
43. Tian L, Noelle RJ, Lawrence DA. Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur J Immunol 1995;25:306-309.
44. Bermudez LE, Young LS. Tumor necrosis factor alpha stimulates mycobactericidal/mycobacteriostatic activity in human macrophages by a protein kinase C-independent pathway. Cell Immunol 1992;144:258-268.
45. Winston BW, Lange-Carter CA, Gardner AM, Johnson GL, Riches DWH. Tumor necrosis factor α rapidly activates the mitogen-activated protein kinase (MAPK) cascade in a MAPK kinase kinase-dependent, c-Raf-1-independent fashion in mouse macrophages. Proc Natl Acad Sci USA 1995;92:1614-1618.
46. Riches DW, Chan ED, Winston BW. TNF-alpha-induced regulation and signalling in macrophages. Immunobiology 1996;195:477-490.
47. Rose DM, et al. Fc gamma receptor cross-linking activates p42, p38, and JNK/SAPK mitogen-activated protein kinases in murine macrophages: role for p42MAPK in Fc gamma receptor-stimulated TNF-alpha synthesis. J Immunol 1997;158:3433-3438.
48. Vogel SN, Fitzgerald KA, Fenton MJ. TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. Mol Interv 2003;3:466-477.
49. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
50. Adams DO, Hamilton TA. The cell biology of macrophage activation. Ann Rev Immunol 1984;2:283-318.
51. Drysdale BE, Agaarwal S, Shin HS. Macrophage mediated tumoricidal activity: mechanisms of activation and cytotoxicity. Prog Allergy 1988;40:111-161.
52. Collart MA, Belin D, Vassalli J-D, de Kossodo S, Vassalli P. Gamma-interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressers. J Exp Med 1986;164:2113-2118.
53. Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an 1-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur J Immunol 1992;22:2501-2506.
54. Stout RD, Suttles J. T cell signaling of macrophage function in inflammatory disease. Front Biosci 1997;2:d197-d206.
55. Nathan CF, Murray HW, Wiebe ME, Rubin BY. Identification of gamma interferon as the lymphokine that activates human macrophage oxidative metabolism and antibacterial activity. J Exp Med 1983;158:670.
56. Hayakawa H, Sato A, Yagi T, Uchiyama H, Ide K, Nakano M. Superoxide generation by alveolar macrophages from aged rats: improvement by in vitro treatment with IFN-gamma. Mech Ageing Dev 1995;80:199-211.
57. Goerdt S, et al. Alternative versus classical activation of macrophages. Pathobiology 1999;67:222-226.
58. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991;174:1549-1555.
59. Florentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-3822.
60. Oswald IP, Wynn TA, Sher A, James SL. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. Proc Natl Acad Sci USA 1992;89:8676-8680.
61. Oswald IP, Gazzinelli RT, Sher A, James SL. IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. J Immunol 1992;148:3578-3582.
62. Abramson SL, Gallin JI. IL-4 inhibits superoxide production by human mononuclear phagocytes. J Immunol 1990;144:625-630.
63. Appelberg R, Orme IM, Pinto de Sousa MI, Silva MT. In vitro effects of interleukin-4 on interferon-gamma-induced macrophage activation. Immunology 1992;76:553-559.
64. Cheung DL, Hart PH, Vitti GF, Whitty GA, Hamilton JA. Contrasting effects of interferon-gamma and interleukin-4 on the interleukin-6 activity of stimulated human monocytes. Immunology 1990;71:70-75.
65. Hart PH, Vitti GF, Burgess DR, Whitty GA, Piccoli DS, Hamilton JA. Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor α, interleukin 1 and prostaglandin E2. Proc Natl Acad Sci USA 1989;86:3803-3807.
66. D'Andrea A, Ma X, Aste Amezaga M, Paganin C, Trinchieri G. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production. J Exp Med 1995;181:537-546.
67. Goerdt S, Orfanos CE. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999;10:137-142.
68. Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 1992;176:287-292.
69. Anderson CF, Gerber JS, Mosser DM. Modulating macrophage function with IgG immune complexes. J Endotoxin Res 2002;8:477-481.
70. Anderson CF, Lucas M, Gutierrez-Kobeh L, Field AE, Mosser DM. T cell biasing by activated dendritic cells. J Immunol 2004;173:955-961.
71. Dobrovolskaia MA, et al. Induction of in vitro reprogramming by Toll-like receptor (TLR) 2 and TLR4 agonists in murine macrophages: effects of TLR 'homotolerance' versus 'heterotolerance' on NF-kappa B signaling pathway components. J Immunol 2003;170:508-519.
72. Lang R, Patel D, Morris JJ, Rutschman RL, Murray PJ. Shaping gene expression in activated and resting primary macrophages by IL-10. J Immunol 2002;169:2253-2263.
73. Williams L, Jarai G, Smith A, Finan P. IL-10 expression profiling in human monocytes. J Leukoc Biol 2002;72:800-809.
74. Wells CA, et al. Genetic control of the innate immune response. BMC Immunol 2003;4:5-23.
75. Elenkov IJ, Chrousos GP. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann NY Acad Sci 2002;966:290-303.
76. Tanaka KF, Kashima H, Suzuki H, Ono K, Sawada M. Existence of functional beta1- and beta2-adrenergic receptors on microglia. J Neurosci Res 2002;70:232-237.
77. Zinyama RB, Bancroft GJ, Sigola LB. Adrenaline suppression of the macrophage nitric oxide response to lipopolysaccharide is associated with differential regulation of tumour necrosis factor-alpha and interleukin-10. Immunology 2001;104:439-446.
78. Lorton D, Lubahn C, Bellinger DL. Potential use of drugs that target neural-immune pathways in the treatment of rheumatoid arthritis and other autoimmune diseases. Curr Drug Targets Inflamm Allergy 2003;2:1-30.
79. Bacle F, Haeffner-Cavaillon N, Laude M, Couturier C, Kazatchkine MD. Induction of IL-1 release through stimulation of the C3b/C4b complement receptor type one (CR1,CD35) on human monocytes. J Immunol 1990;144:147-152.
80. Medvedev AE, et al. Involvement of CD14 and complement receptors CR3 and CR4 in nuclear factor-kappaB activation and TNF production induced by lipopolysaccharide and group B streptococcal cell walls. J Immunol 1998;160:4535-4542.
81. Lipschitz DA. Age-related declines in hematopoietic reserve capacity. Semin Oncol 1995;22:3-5.
82. Yuasa T, et al. Deletion of fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis. J Exp Med 1999;189:187-194.
83. - generation. Mol Immunol 1990;27:829-838.
84. Sutterwala FS, Noel GJ, Salgame P, Mosser DM. Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I. J Exp Med 1998;188:217-222.
85. Alonso A, Carvalho J, Alonso-Torre SR, Nunez L, Bosca L, Crespo MS. Nitric oxide synthesis in rat peritoneal macrophages is induced by IgE/DNP complexes and cyclic AMP analogues. J Immunol 1995;154:6475-6483.
86. Armant M, Rubio M, Delespesse G, Sarfati M. Soluble CD23 directly activates monocytes to contribute to the antigen-independent stimulation of resting T cells. J Immunol 1995;155:4868-4875.
87. Armant M, Ishihara H, Rubio M, Delespesse G, Sarfati M. Regulation of cytokine production by soluble CD23: costimulation of interferon-γ secretion and triggering of tumor necrosis factor-α release. J Exp Med 1994;180:1005-1011.
88. Girardin SE, Philpott DJ. Mini-review: the role of peptidoglycan recognition in innate immunity. Eur J Immunol 2004;34: 1777-1782.
89. Philpott DJ, Girardin SE. The role of Toll-like receptors and Nod proteins in bacterial infection. Mol Immunol 2004;41: 1099-1108.
90. Royet J, Reichhart JM. Detection of peptidoglycans by NOD proteins. Trends Cell Biol 2003;13:610-614.
91. Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 2000;49:497-505.
92. Ricote M, Valledor AF, Glass CK. Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis. Arterioscler Thromb Vasc Biol 2004;24:230-239.
93. Ricote M, Huang JT, Welch JS, Glass CK. The peroxisome proliferator-activated receptor (PPARgamma) as a regulator of monocyte/ macrophage function. J Leukoc Biol 1999;66:733-739.
94. Makowski L, et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 2001;7:699-705.
95. Makowski L, Hotamisligil GS. Fatty acid binding proteins - the evolutionary crossroads of inflammatory and metabolic responses. J Nutr 2004;134:2464S-2468S.
96. Bellingan GJ, et al. Adhesion molecule-dependent mechanisms regulate the rate of macrophage clearance during the resolution of peritoneal inflammation. J Exp Med 2002;196:1515-1521.
97. Lecoanet-Henchoz S, et al. Mouse CD23 regulates monocyte activation through an interaction with the adhesion molecule CD11b/CD18. Eur J Immunol 1997;27:2290-2294.
98. Schmal H, et al. Soluble ICAM-1 activates lung macrophages and enhances lung injury. J Immunol 1998;161:3685-3693.
99. Geng Y, Zhang B, Lotz M. Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J Immunol 1993;151:6692-6700.
100. Huang JT, et al. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 1999;400:378-382.
101. Aronoff DM, Canetti C, Peters-Golden M. Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. J Immunol 2004;173:559-565.
102. Rouzer CA, et al. Cyclooxygenase-1-dependent prostaglandin synthesis modulates tumor necrosis factor-alpha secretion in lipopolysaccharide-challenged murine resident peritoneal macrophages. J Biol Chem 2004;279:34256-34268.
103. Elenkov IJ, Webster E, Papanicolaou DA, Fleisher TA, Chrousos GP, Wilder RL. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol 1998;161: 2586-2593.
104. Marone G, Granata F, Spadaro G, Genovese A, Triggiani M. The histamine-cytokine network in allergic inflammation. J Allergy Clin Immunol 2003;112:S83-S88.
105. Liang CP, et al. Increased CD36 protein as a response to defective insulin signaling in macrophages. J Clin Invest 2004;113: 764-773.
106. Hartman ME, O'Connor JC, Godbout JP, Minor KD, Mazzocco VR, Freund GG. Insulin receptor substrate-2-dependent interleukin-4 signaling in macrophages is impaired in two models of type 2 diabetes mellitus. J Biol Chem 2004;279:28045-28050.
107. Laskin DL, Weinberger B, Laskin JD. Functional heterogeneity in liver and lung macrophages. J Leukoc Biol 2001;70:163-170.
108. Guillemin GJ, Brew BJ. Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukoc Biol 2004;75:388-397.
109. Hanisch UK. Microglia as a source and target of cytokines. Glia 2002;40:140-155.
110. Hesse M, et al. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of 1-arginine metabolism. J Immunol 2001;167:6533-6544.
111. Loke P, Nair MG, Parkinson J, Guiliano D, Blaxter M, Allen JE. IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. BMC Immunol 2002;3:7.
112. Loke P, MacDonald AS, Robb A, Maizels RM, Allen JE. Alternatively activated macrophages induced by nematode infection inhibit proliferation via cell-to-cell contact. Eur J Immunol 2000;30:2669-2678.
113. Steinman RM, Inaba K. Myeloid dendritic cells. J Leukoc Biol 1999;66:205-208.
114. Hamerman JA, Aderem A. Functional transitions in macrophages during in vivo infection with Mycobacterium bovis bacillus Calmette-Guerin. J Immunol 2001;167:2227-2233.
115. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002;23:549-555.
116. Rutherford MS, Witsell A, Schook LB. Mechanisms generating functionally heterogeneous macrophages: chaos revisited. J Leukoc Biol 1993;53:602-618.
117. Witsell AL, Schook LB. Macrophage heterogeneity occurs through a developmental mechanism. Proc Natl Acad Sci USA 1991;88:1963-1967.
118. Takahashi K, Naito M, Takeya M. Development and heterogeneity of macrophages and their related cells through their differentiation pathways. Pathol Int 1996;46:473-485.
119. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003;19:71-82.
120. Kambayashi T, Jacob CO, Strassmann G. IL-4 and IL-13 modulate IL-10 release in endotoxin-stimulated murine peritoneal mononuclear phagocytes. Cell Immunol 1996;171:153-158.
121. Kempermann G, Neumann H. Neuroscience. Microglia: the enemy within? Science 2003;302:1689-1690.
122. Liu B, Hong JS. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 2003;304:1-7.
123. Franceschi C, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann NY Acad Sci 2000;908:244-254.
124. Kerr LD. Inflammatory arthropathy: a review of rheumatoid arthritis in older patients. Geriatrics 2004;59:32-35.
125. Cassetta M, Gorevic PD. Crystal arthritis. Gout and pseudogout in the geriatric patient. Geriatrics 2004;59:25-30.
126. Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004;39:687-699.
127. Casserly I, Topol E. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. Lancet 2004;363:1139-1146.
128. Hakim FT, Flomerfelt FA, Boyiadzis M, Gress RE. Aging, immunity and cancer. Curr Opin Immunol 2004;16:151-156.
129. Tracy RP. Emerging relationships of inflammation, cardiovascular disease and chronic diseases of aging. Int J Obes Relat Metab Disord 2003;27:S29-S34.
130. Ashcroft GS, Horan MA, Ferguson MW. Aging alters the inflammatory and endothelial cell adhesion molecule profiles during human cutaneous wound healing. Lab Invest 1998;78:47-58.
131. Swift ME, Burns AL, Gray KL, DiPietro LA. Age-related alterations in the inflammatory response to dermal injury. J Invest Dermatol 2001;117:1027-1035.
132. Swift ME, Kleinman HK, DiPietro LA. Impaired wound repair and delayed angiogenesis in aged mice. Lab Invest 1999;79:1479-1487.
133. Ortega E, Garcia JJ, De la FM. Modulation of adherence and chemotaxis of macrophages by norepinephrine. Influence of ageing. Mol Cell Biochem 2000;203:113-117.
134. Antonini JM, et al. Effect of age on respiratory defense mechanisms: pulmonary bacterial clearance in Fischer 344 rats after intratracheal instillation of Listeria monocytogenes. Chest 2001;120:240-249.
135. Albright JW, Albright JF. Ageing alters the competence of the immune system to control parasitic infection. Immunol Lett 1994;40:279-285.
136. Bradley SF, Kauffman CA. Aging and the response to Salmonella infection. Exp Gerontol 1990;25:75-80.
137. Mancuso P, McNish RW, Peters-Golden M, Brock TG. Evaluation of phagocytosis and arachidonate metabolism by alveolar macrophages and recruited neutrophils from F344xBN rats of different ages. Mech Ageing Dev 2001;122:1899-1913.
138. Seth A, Nagarkatti M, Nagarkatti PS, Subbarao B, Udhayakumar V. Macrophages but not B cells from aged mice are defective in stimulating autoreactive T cells in vitro. Mech Ageing Dev 1990;52:107-124.
139. Garg M, Luo W, Kaplan AM, Bondada S. Cellular basis of decreased immune responses to pneumococcal vaccines in aged mice. Infect Immun 1996;64:4456-4462.
140. Effros RB, Walford RL. The effect of age on the antigen-presenting mechanism in limiting dilution precursor cell frequency analysis. Cell Immunol 1984;88:531-539.
141. Haruna H, et al. Abnormalities of B cells and dendritic cells in SAMP1 mice. Eur J Immunol 1995;25:1319-1325.
142. Zissel G, Schlaak M, Muller-Quernheim J. Age-related decrease in accessory cell function of human alveolar macrophages. J Invest Med 1999;47:51-56.
143. Ashcroft GS, Horan MA, Ferguson MW. The effects of ageing on wound healing: immunolocalisation of growth factors and their receptors in a murine incisional model. J Anat 1997;190:351-365.
144. Kraatz J, Clair L, Rodriguez JL, West MA. Macrophage TNF secretion in endotoxin tolerance: role of SAPK, p38, and MAPK. J Surg Res 1999;83:158-164.
145. Saurwein-Teissl M, Blasko I, Zisterer K, Neuman B, Lang B, Grubeck-Loebenstein B. An imbalance between pro- and antiinflammatory cytokines, a characteristic feature of old age. Cytokine 2000;12:1160-1161.
146. Inamizu T, Chang MP, Makinodan T. Influence of age on the production and regulation of interleukin-1 in mice. Immunology 1985;55:447-455.
147. Wallace PK, Eisenstein TK, Meissler JJ Jr, Morahan PS. Decreases in macrophage mediated antitumor activity with aging. Mech Ageing Dev 1995;77:169-184.
148. Boehmer ED, Goral J, Faunce DE, Kovacs EJ. Age-dependent decrease in Toll-like receptor 4-mediated proinflammatory cytokine production and mitogen-activated protein kinase expression. J Leukoc Biol 2004;75:342-349.
149. Corsini E, et al. A defective protein kinase C anchoring system underlying age-associated impairment in TNF-alpha production in rat macrophages. J Immunol 1999;163:3468-3473.
150. Hayakawa H, Sato A, Yagi T, Uchiyama H, Ide K, Nakano M. Superoxide generation by alveolar macrophages from aged rats: improvement by in vitro treatment with IFN-gamma. Mech Ageing Dev 1995;80:199-211.
151. Alvarez E, Machado A, Sobrino F, Santa MC. Nitric oxide and superoxide anion production decrease with age in resident and activated rat peritoneal macrophages. Cell Immunol 1996;169:152-155.
152. Hoellman JR, Suttles J, Stout RD. Panning T cells on vascular endothelial cell monolayers: a rapid method for enriching naive T cells. Immunobiology 2001;203:769-777.
153. Khare V, Sodhi A, Singh SM. Effect of aging on the tumoricidal functions of murine peritoneal macrophages. Nat Immun 1996;15:285-294.
154. Kissin E, Tomasi M, McCartney-Francis N, Gibbs CL, Smith PD. Age-related decline in murine macrophage production of nitric oxide. J Infect Dis 1997;175:1004-1007.
155. Alvarez E, Machado A, Sobrino F, Santa Maria C. Nitric oxide and superoxide anion production decrease with age in resident and activated rat peritoneal macrophages. Cell Immunol 1996;169:152-155.
156. Ding A, Hwang S, Schwab R. Effect of aging on murine macrophages. Diminished response to IFN-gamma for enhanced oxidative metabolism. J Immunol 1994;153:2146-2152.
157. Alvarez E, Santa MC, Machado A. Respiratory burst reaction changes with age in rat peritoneal macrophages. Biochim Biophys Acta 1993;1179:247-252.
158. Alvarez E, Conde M, Machado A, Sobrino F, Santa Maria C. Decrease in free-radical production with age in rat peritoneal macrophages. Biochem J 1995;312:555-560.
159. Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S. Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol 2002;169:4697-4701.
160. Hayek MG, et al. Enhanced expression of inducible cyclooxygenase with age in murine macrophages. J Immunol 1997;159:2445-2451.
161. Wu D, et al. Age-associated increase in PGE2 synthesis and COX activity in murine macrophages is reversed by vitamin E. Am J Physiol 1998;275:C661-C668.
162. Spencer NF, Norton SD, Harrison LL, Li GZ, Daynes RA. Dysregulation of IL-10 production with aging: possible linkage to the age-associated decline in DHEA and its sulfated derivative. Exp Gerontol 1996;31:393-408.
163. Sadeghi HM, Schnelle JF, Thoma JK, Nishanian P, Fahey JL. Phenotypic and functional characteristics of circulating monocytes of elderly persons. Exp Gerontol 1999;34:959-970.
164. Yoon P, Keylock KT, Hartman ME, Freund GG, Woods JA. Macrophage hyporesponsiveness to interferon-gamma in aged mice is associated with impaired signaling through Jak-STAT. Mech Ageing Dev 2004;125:137-143.
165. Kohut ML, Senchina DS, Madden KS, Martin AE, Felten DL, Moynihan JA. Age effects on macrophage function vary by tissue site, nature of stimulant, and exercise behavior. Exp Gerontol 2004;39:1347-1360.
166. Shimada Y, Ito H. Heterogeneous aging of macrophage-lineage cells in the capacity for TNF production and self renewal in C57BL/6 mice. Mech Ageing Dev 1996;87:183-195.
167. Matsui S, et al. Role of the endogenous prostaglandin E2 in human lung fibroblast interleukin-11 production. Respir Med 1999;93:637-642.
168. Wang CQ, Udupa KB, Xiao H, Lipschitz DA. Effect of age on marrow macrophage number and function. Aging (Milano) 1995;7:379-384.
169. Doria G, Mancini C, Utsuyama M, Frasca D, Hirokawa K. Aging of the recipients but not of the bone marrow donors enhances autoimmunity in syngeneic radiation chimeras. Mech Ageing Dev 1997;95: 131-142.
170. Timm JA, Thoman ML. Maturation of CD4+ lymphocytes in the aged microenvironment results in a memory-enriched population. J Immunol 1999;162:711-717.
171. Stephan RP, Lill-Elghanian DA, Witte PL. Development of B cells in aged mice: decline in the ability of pro-B cells to respond to IL-7 but not to other growth factors. J Immunol 1997;158:1598-1609.
172. Mu XY, Thoman ML. Aging affects the regeneration of the CD8+ T cell compartment in bone marrow transplanted mice. Mech Ageing Dev 2000;112: 113-124.
173. Cheleuitte D, Mizuno S, Glowacki J. In vitro secretion of cytokines by human bone marrow: effects of age and estrogen status. J Clin Endocrinol Metab 1998;83: 2043-2051.
174. Stephan RP, Reilly CR, Witte PL. Impaired ability of bone marrow stromal cells to support B-lymphopoiesis with age. Blood 1998;91:75-88.
175. Aydar Y, Balogh P, Tew JG, Szakal AK. Follicular dendritic cells in aging, a 'bottle-neck' in the humoral immune response. Ageing Res Rev 2004;3:15-29.
176. Aydar Y, Balogh P, Tew JG, Szakal AK. Altered regulation of Fc gamma RII on aged follicular dendritic cells correlates with immunoreceptor tyrosine-based inhibition motif signaling in B cells and reduced germinal center formation. J Immunol 2003;171:5975-5987.
177. Lung TL, Saurwein-Teissl M, Parson W, Schonitzer D, Grubeck-Loebenstein B. Unimpaired dendritic cells can be derived from monocytes in old age and can mobilize residual function in senescent T cells. Vaccine 2000;18:1606-1612.
178. Chen LC, Pace JL, Russell SW, Morrison DC. Altered regulation of inducible nitric oxide synthase expression in macrophages from senescent mice. Infect Immun 1996;64:4288-4298.
179. Burgess W, et al. The immune-endocrine loop during aging: role of growth hormone and insulin-like growth factor-I. Neuroimmunomodulation 1999;6:56-68.
180. Lavrovsky Y, Chatterjee B, Clark RA, Roy AK. Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp Gerontol 2000;35:521-532.
181. Poynter ME, Daynes RA. Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. J Biol Chem 1998;273:32833-32841.
182. Spencer NF, Poynter ME, Im SY, Daynes RA. Constitutive activation of NF-kappa B in an animal model of aging. Int Immunol 1997;9:1581-1588.
183. Mosley RL. Aging, immunity and neuroendocrine hormones. Adv Neuroimmunol 1996;6:419-432.
184. Stout RD, Suttles J. T cell signaling of macrophage function in inflammatory disease. Front Biosci 1997;2:d197-d206.
185. Kennedy MK, et al. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur J Immunol 1996;26:370-378.
186. Cox GW, Melillo G, Chattopadhyay U, Mullet D, Fertel RH, Varesio L. Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity. J Immunol 1992;149:3290-3296.
187. Leenen PJM, Canono BP, Drevets DA, Voerman JSA, Campbell PA. TNP-α and IFN-γ stimulate a macrophage precursor cell line to kill Listeria monocytogenes in a nitric oxide-independent manner. J Immunol 1994;153:5141-5147.
188. Winston BW, Lange-Carter CA, Gardner AM, Johnson GL, Riches DW. Tumor necrosis factor alpha rapidly activates the mitogen-activated protein kinase
189. Ravetch JV, Clynes RA. Divergent roles for Fc receptors and complement in vivo. Annu Rev Immunol 1998;16:421-432.
190. Luxembourg AT, Cooper NR. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV. J Immunol 1994;153:4448-4457.
191. Aubry JP, et al. The 25-kDa soluble CD23 activates type III constitutive nitric oxide synthase activity via CD11b and CD11c expressed by human monocytes. J Immunol 1997;159:614-622.
192. Renier G, Clement I, Desfaits AC, Lambert A. Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-alpha production. Endocrinology 1996;137:4611-4618.